CEP55 and non-small cell lung carcinoma: In multivariate analysis, CEP55 expression was associated with age of patients with NSCLC (HR = 0.983, 0.966~1.001, P = 0.061), gender (HR = 0.789, 0.499~1.247, P = 0.310), grade (HR = 1.444, 0.764~2.731, P = 0.258), stage (HR = 0.926, 0.567~1.513, P = 0.760), T (HR = 0.839, 0.596~1.181, P = 0.314), N (HR = 0.749, 0.522~1.075, P = 0.117), M (HR = 0.853, 0.372–1.957, P = 0.708).